pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 1·1 min read
save

General Catalyst uses Summa Health as test bed for AI-driven patient support tools

Jun 1, 2026·read at STAT ↗Positive

General Catalyst bought Ohio safety‑net hospital Summa Health in October and is using it to trial new health‑technology tools. Executives from the holding company, Health Assurance Transformation Company, described the ongoing "transformation" plan eight months after the acquisition.

Patients in northeast Ohio are now receiving automated phone calls powered by artificial intelligence. The calls help them prepare for upcoming surgeries and guide them through care steps after they leave the hospital.

The firm says Summa Health will serve as a proving ground, and successful tools will be rolled out to more than two dozen partner health systems in the HATCo network.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Executives reveal tech initiatives at Summa Health, eight months after General Catalyst acquisition”

read at STAT ↗
541 words · retrieved Jun 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.
topics
Rare Disease

related stories

  • Apr 28Opinion: Healthcare or health care? Help STAT decideSTAT
  • Apr 28Opinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug developmentSTAT
  • Apr 28Pfizer deals extend patent life for a top-selling rare disease drugBioPharma Dive
  • Apr 28STAT+: Supreme Court to hear case about ‘skinny labeling’ and generic accessSTAT
  • Apr 28Rocket's PRV goes for $180M; Oruka targets $500M offeringEndpoints